Randomized trial · people
Teriparatide: richer early callus in distal radial fractures
Checked against the paper Randomized trialPublished by PepVault
The takeaway
In a small, unplanned look within a placebo-controlled trial, teriparatide was linked to better-looking early callus in wrist fractures. This is an early signal, not a confirmed healing benefit.
- Kind
- Randomized trial
- Studied in
- People
- Number studied
- 27
- Published
- 2010
- Journal
- Acta Orthop
What they tested
The team wanted to know whether teriparatide changed how the callus (the new tissue forming at a healing break) looked on X-ray 5 weeks after a distal radial fracture, a break of the forearm bone near the wrist.
How the study was done
A post hoc look at 27 patients treated at Linköping University Hospital as part of a larger international, randomized multicenter trial of distal radial fractures handled without surgery, comparing placebo (a dummy treatment), a low-dose 20 microg per day arm and a high-dose 40 microg per day arm. Each callus was scored blind at 5 weeks as rich, intermediate or poor.

What they found
Each callus group held 9 patients. Of the 9 with rich callus, none had placebo, 3 had low-dose and 6 had high-dose teriparatide. Of the 9 with intermediate callus, 1 had placebo, 5 had low-dose and 3 had high-dose. Of the 9 with poor callus, 7 had placebo, 1 had low-dose and 1 had high-dose (p < 0.001).
What it doesn’t show
This was a small post hoc subgroup from one center, and callus quality was not an outcome planned in the trial's protocol, so the authors urge caution. It scored X-ray appearance at one early time point and did not test whether patients healed or regained function better.
The paper
Aspenberg and Johansson Teriparatide improves early callus formation in distal radial fractures. Acta Orthop. 2010.
The compound
More studies on Teriparatide
- Abaloparatide, teriparatide beat other drugs on spine BMD in menMeta-analysis · people · 2025
- Teriparatide cut fracture risk vs bisphosphonates (RR 0.61)Meta-analysis · people · 2024
- Abaloparatide: larger hip BMD gains than teriparatide at 24 weeksMeta-analysis · people · 2023
- Teriparatide: more bony union at 6 months than zoledronate after PLIFRandomized trial · people · 2022
- Teriparatide: 45.4% of jaw osteonecrosis lesions resolved by 52 weeksRandomized trial · people · 2020
- Teriparatide: fewer new vertebral fractures than risedronate in VERORandomized trial · people · 2018
- Every study on Teriparatide
Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.